| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |